期刊文献+

冻干重组人三突变型HIF-1α腺病毒生物学效应考察

Characterization of the biological activities of lyophilized recombinant adenovirus expressing the triple mutant of hypoxia inducible factor-1α
下载PDF
导出
摘要 目的研究冻干对重组人三突变型HIF-1α腺病毒(Ad-HIF-1α-564/402/803)生物学效应的影响。方法将前期构建的Ad-HIF-1α-564/402/803在HEK293A细胞中进行扩增,用氯化铯浓度梯度离心法进行腺病毒纯化,X-Gal染色法测定重组腺病毒转染效率,在适宜的条件下制成冻干剂。采用MTS试剂盒观察冻干前后Ad-HIF-1α-564/402/803对hMVECs增殖的影响。分别在冻干前、冻干后1 d、6月、12月四个时间点提取病毒DNA,进行PCR及PCR产物测序鉴定重组人三突变型HIF-1α腺病毒基因;并在4个时间点以Ad-HIF-1α-564/402/803转染hMVECs,提取蛋白进行western blot检测HIF-1α蛋白的表达。结果 X-gal染色显示MOI为100pfu/cell时,转染效率趋于稳定。冻干前后重组人三突变型HIF-1α腺病毒对hMVECs增殖影响无显著差异(P>0.05)。经PCR及基因测序鉴定,在四个时间点,腺病毒所携带的目的基因信息无丢失或突变,HIF-1α蛋白表达无差异(P>0.05)。结论冻干能够长期保持重组人三突变型HIF-1α腺病毒的高生物活性。 Objective To investigate the influence of lyophilization on the biological activity of recombinant adenovirus-mediated triple mutant of hypoxia inducible factor-1α(Ad-HIF-1α-564/402/803).Methods Ad-HIF-1α-564/402/803 was amplified from HEK293A cells and purified by ultracentrifugation in CsCl gradient solutions.The infection efficiency was observed by X-gal staining.The lyophilized adenovirus was prepared under appropriate conditions.Before and after lyophilization,the effect of Ad-HIF-1α-564/402/803 on hMVEC proliferation was evaluated by MTS assay.The recombinant adenovirus was confirmed by PCR and DNA sequence analysis before and 1 day,6 months and 12 months after lyophilization,and hMVECs infected with Ad-HIF-1α-564/402/803 at these time points were examined for HIF-1α protein expression using Western blotting.Results No significant changes were observed in the effect of lyophilized Ad-HIF-1α-564/402/803 on hMVECs proliferation at the optimal multiplicity of infection of 100 pfu/cell(P0.05).At the 4 time points,the recombinant adenovirus HIF-1α showed no structural alterations or significant changes in the expression level of HIF-1α protein in the transfected hMVECs(P0.05).Conclusion Lyophilized Ad-HIF-1α-564/402/803 can maintain its biological activities for a long time.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2011年第3期469-472,共4页 Journal of Southern Medical University
基金 国家自然科学基金(30370587) 国家青年科学基金(30800462)~~
关键词 HIF-1Α 重组腺病毒 冷冻干燥 生物学活性 hypoxia inducible factor-1 recombinant adenovirus lyophilization biological activities
  • 相关文献

参考文献11

  • 1Tckin D, Dursun AD, Xi L. Hypoxia inducible factor 1 (HIF-I) and cardioprotcction[J]. Acta Pharmacol Sin, 2010, 31(9): 1085-94.
  • 2Chua YL, Dufour E, Dassa EP, et al. Stabilization of hypoxiainducible factor, lalpha protein in hypoxia occurs independently of mitochondrial reactive oxygen species production[J]. J Biol Chem, 2010, 285(41): 31277-84.
  • 3Kaelin WG Jr, Ratcliffc PJ. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway[J]. Mol Cell, 2008, 30 (4): 393-402.
  • 4Wang Y, Feng C, Xue J, et al. Adenovirus-mediatcd hypoxia-inducible factor 1 alpha double-mutant promotes differentiation of bone marrow stem cells to cardiomyocytes[J]. J Physiol Sci, 2009, 59(6): 413-20.
  • 5Ke Q, Costa M. Hypoxia-inducible factor-I (HIF-I)[J]. Mol Pharmacol, 2006, 70(5): 1469-80.
  • 6赖艳娴,刘城,王月刚,谢宜军,童锴,胡英芳,韦莉莉,吴平生.人3突变型低氧诱导因子1α真核表达载体和腺病毒表达载体的构建及鉴定[J].中国医科大学学报,2008,37(1):86-89. 被引量:8
  • 7Ferraro B, Cruz YL, Coppola D, ctal. lntradermal delivery of plasmid VEGF(165) by clcctroporation promotcs wound healing [J]. Mol Thor, 2009, 17(4): 651-7.
  • 8Yamamoto A, Kormann M, Rosenccker J, et al. Current prospects for mRNA gene dclivery[J]. Eur J Pharm Biopharm, 2009, 71(3): 484-9.
  • 9Rajagopalan S, Olin J, Deitcher S, et al. Use of a eonstitutivel'y active hypoxia-inducible factor-lalpha transgene as a therapeutic strategy in no-option critical limb ischemia patients: phase I dose-escalation experience[J]. Circulation, 2007, 115(10): 1234-43.
  • 10Chen C, Han D, Cai C, et al. An overview of liposome lyophilization and its future potential[J]. J Control Release, 2010, 142(3): 299-311.

二级参考文献22

  • 1王玉琳,曾鸣,王玲,刘晓凡,韩德胜,李根明.病毒活疫苗冻干保护剂筛选研究[J].微生物学免疫学进展,1996,24(1):22-27. 被引量:15
  • 2王韵,曹旭,高山红,李雪芹,张晶,王淑真,周玲,张福利,章新华,洪洋,王怀良.腺苷对家兔心肌缺血再灌注损伤的保护作用[J].中国医科大学学报,2006,35(6):568-570. 被引量:4
  • 3Rexroad J.Structural stability of adenovirus type 5.J Pharm Sci,2003,92(3):665-678.
  • 4Croyle MA,Cheng X,Wilson JM,et al.Development of formulations that enhance physical stability of viral vectors for gene therapy.Gene Therapy,2001,8(17):1281-1290.
  • 5Ugai H,Watanabe S,Suzuk IE,et al.Stability of a recombinant adenoviral vector.Jpn J Cancer Res,2002,93(5):598-603.
  • 6Evans RK,Nawrocki DK,Isopi LA,et al.Development of stable liquid formulations for adenovirus-based vaccines.J Pharm Sci,2004,93(10):2458-2475.
  • 7Hosokawa M,Hama S,Mandai K,et al.Preparation of purified,sterilized,and stable adenovirus vectors using albumin.J Virol Methods,2002,103 (2):191-199.
  • 8MASSON N,WILIAM C, MAXWELL PH, et al. Independent function of two deslruction domains in hypoxia- inducible factor-alpha chains activated by prolyl hydroxylation [ J ]. EMBO J, 2001,20 ( 18 ) : 5197-5206.
  • 9JAAKKOLA P, MOLE DR, TIAN YM, et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation[J]. Science, 2001,292(5516) :468-472.
  • 10MAXWELL PH. Hypoxia- inducible actor as a physiological regulator. Exp Physiol [J]. 2005,90(6) : 791-797.

共引文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部